James M. Daly, Director at ACADIA PHARMACEUTICALS INC (ACAD), sold 30,000 shares at $37.79 ($1.1M) on 2019-09-09, disclosed to the SEC on 2019-09-11.
Open-market sale of $1.1M ACAD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.79 | 29,600 | $1.1M | 98.6% |
| 2 | $38.39 | 400 | $15K | 1.4% |
| Total | $37.80 avg | 30,000 | $1.1M | 100% |
| Filing → |
| MDGL | SELL | 2024-04-03 | $15.9M | — | Filing → |
| HALO | SELL | 2023-08-15 | $875K | — | Filing → |
| HALO | SELL | 2020-11-25 | $838K | — | Filing → |